methyldimethylaminoazobenzene has been researched along with (2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawai, K; Moriwaki, H; Muto, Y; Ninomiya, M; Seto, T; Suzuki, Y | 1 |
| Friedman, SL; Hashimoto, M; Ishibashi, N; Kagawa, M; Kohno, H; Kojima, S; Matsushima-Nishiwaki, R; Moriwaki, H; Okuno, M; Sano, T; Suzuki, R; Takano, Y; Tanaka, T; Tsurumi, H; Yamamoto, M | 1 |
2 other study(ies) available for methyldimethylaminoazobenzene and (2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid
| Article | Year |
|---|---|
Inhibitory effects of synthetic acidic retinoid and polyprenoic acid on the development of hepatoma in rats induced by 3'-methyl-N, N-dimethyl-4-aminoazobenzene.
Topics: Animals; Liver Neoplasms, Experimental; Male; Methyldimethylaminoazobenzene; Pyridines; Rats; Rats, Inbred F344; Retinol-Binding Proteins; Retinol-Binding Proteins, Cellular; Tretinoin | 1988 |
Prevention of rat hepatocarcinogenesis by acyclic retinoid is accompanied by reduction in emergence of both TGF-alpha-expressing oval-like cells and activated hepatic stellate cells.
Topics: Actins; Adenoma; Animals; Antineoplastic Agents; Carcinoma; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Fibrosis; Liver; Liver Neoplasms, Experimental; Male; Methyldimethylaminoazobenzene; Rats; Rats, Inbred F344; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transforming Growth Factor alpha; Tretinoin | 2005 |